Metabolomic Diagnostics on track with pre-eclampsia screening test
Metabolomic Diagnostics’ fresh €1.6 million funding round could see it bring to market PrePsia, its pre-eclampsia screening test, as early as next year.
“We’re aiming to have a product on the market by the time those funds run out,” said Charles Garvey, chief executive, Metabolomic Diagnostics.
“We’re hoping to have the first release of the product next year. Science doesn’t work in a linear fashion, so it may take longer than we’d hope, ...